FDA approves more drugs faster than Europe

Washington • Contrary to some political claims, the U.S. Food and Drug Administration approved more drugs, and two to three months faster on average, than European regulators did in recent years, new research shows. “It’s an urban myth” that the FDA is slower than other countries to clear promising treatments for patients, said the agency’s longtime cancer drugs chief, Dr. Richard Pazdur. He had no role in the approval rate research, which was published Wednesday in the New England Journal of Me...

Share this post